Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Here’s What’s Going On With Novavax Shares

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 3.05% to $58.43 Monday afternoon in sympathy with BioNTech SE – ADR (NASDAQ: BNTX), which reported worse-than-expected second-quarter results.
byHenry Khederian
August 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Novavax, Inc. (NASDAQ:NVAX) shares are trading lower by 3.05% to $58.43 Monday afternoon in sympathy with BioNTech SE – ADR (NASDAQ:BNTX), which reported worse-than-expected second-quarter results.

What Happened?

BioNTech believes the development of the pandemic remains dynamic, causing a re-phasing of orders and leading to fluctuations in quarterly revenues. 

This revenue fluctuation caused by the re-phasing of orders is expected to remain over the rest of the financial year with uptake in demand in key markets in fourth-quarter FY22 related to the Omicron-adapted bivalent vaccine, subject to regulatory approval… Read More

According to data from Benzinga Pro, Novavax has a 52-week high of $277.80 and a 52-week low of $34.88.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

US Stocks Notch Biggest Annual Decline Since 2008, Market Volatility Increases

By Lisa Levin
January 3, 6:46 AM
US stocks closed lower on last trading session of the year, with the three main indices recording their first yearly decline since 2018. The Fed's aggressive rate increases impacted stocks last year, with the benchmark S&P 500 losing 19.4%, and the Dow dropping around 9% in 2022. Growth stocks remained under pressure from increasing yields for most part of the year.

AMZN